Abstract
Communication between physician, patient, and family becomes intense and fraught with problems in the setting of advanced disease. Protocols for end-of-life communication have been developed by various authors, but they have focused primarily on delivery of "bad news" in an individual encounter. This article addresses the need for ongoing coversation throughout the progression from life-prolonging treatment to hospice care. A case study illustrates the utility of this approach.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Stewart M, Brown JB, Boon H, et al.: Evidence on patient-doctor communication. Cancer Prevent Control 1999, 3:25–30.
Curtis JR, Patrick DL, Caldwell E, et al.: The quality of patientdoctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care clinicians. AIDS 1999, 13:1123–1131.
Hoffman J, Wenger N, Davis R, et al.: Patient preferences for communication with physicians about end-of-life decisions. Ann Intern Med 1997, 127:1–12.
Fallowfield L, Ford S, Lewis S: Information preferences of patients with cancer. Lancet 1994, 344:8936.
Buckman R: How to Break Bad News: A Guide for Health Care Professionals. Baltimore: Johns Hopkins University Press; 1992.
Quirt CF, Mackillop WJ, Ginsburg AD, et al.: Do doctors know when their patients don’t? A survey of doctor-patient communication in lung cancer. Lung Cancer 1997, 18:1–20.
Miller SM: Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol 1987, 52:345–353.
Miller SM: Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease: implications for cancer screening and management. Cancer 1995, 76:167–177.
Ong LM, Visser MR, van Zuuren FJ, et al.: Cancer patients’ coping styles and doctor-patient communication. Psychooncology 1999, 8:155–166.
Orentilicher D: The illusion of patient choice in end-of-life decisions. JAMA 1992, 267:2101–2104.
Porter WG: Truth telling and hope: the dilemma of modern medicine. N C Med J 1999, 60:142–148. Good philosophical exploration of communication issues surrounding death and dying.
Eidinger RN, Schapira DV: Cancer patients’ insights into their treatment, prognosis and unconventional therapies. Cancer 1984, 53:2736–2740.
Weeks JC, Cook EF, O’Day, SJ, et al.: Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 1998, 279:1709–1714. Excellent summary of data related to importance of prognostic information and patient choice.
Bretscher, M: Caring for dying patients: What is right? J Clin Oncol 2000, 18:233–234.
Ng KK, Kris MG, Ginsberg RJ, et al.: Induction chemotherapy employing dose intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma. Cancer 1999, 86:1189–1107.
Adelstein DJ, Rice TW, Rybicki LA, et al.: Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small cell lung cancer. Am J Clin Oncol 1999, 22:237–242.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LeGrand, S.B. Communication in advanced disease. Curr Oncol Rep 2, 358–361 (2000). https://doi.org/10.1007/s11912-000-0030-z
Issue Date:
DOI: https://doi.org/10.1007/s11912-000-0030-z